ROK — Rockwell Automation, Inc.

The Q3 FY26 beat (adjusted EPS $3.49 vs. $3.38 est.) and raised FY26 EPS guidance to $13.00-$13.30 confirm a solid cyclical recovery, but sentiment is not euphoric. As of 2026-08-27, the consensus rating is Hold (11 Buy / 28 Hold / 2 Sell), the stock is below its 20/50-day moving averages, RSI is 41.7, and at least one analyst trimmed their target on valuation in August 2026. In other words, the tape is constructive but cautious.

This is a clear cyclical inflection, not a blip. Revenue fell from $2.56B in Sep-23 to a $1.88B trough in Dec-24, then reaccelerated: Sep-25 revenue was $2.32B (+13.8% YoY), Dec-25 was $2.11B (+11.9% YoY), Mar-26 was $2.24B (+11.8% YoY), and Jun-26 was $2.31B (+7.9% YoY, +10% organic). Operating leverage is visible too: FMP operating income went from $342M in Dec-24 to $654M in Jun-26, and management reports adjusted enterprise operating margin expanded 280 bps YoY to 22.3%. EPS progression shows the same up-trend: $1.61 in Dec-24, rising to $3.62 in Jun-26, with Sep-25's $1.23 distorted by a one-off/R&D item. Process industries and food & beverage remain the laggards, which is the remaining upside.

At $433 as of 2026-08-27, ROK is not cheap. TTM P/E is 40.5x, though that is distorted upward by the depressed Sep-25 quarter; forward P/E on FY26E EPS of $13.21 is roughly 32.8x. That is above ROK's own 5-year average P/E of 30.7x. P/S is 5.37x vs. the 5-year average of 4.03x, and P/B is 13.9x. The valuation is rich vs. its own history and leaves little room for a miss, even though the growth profile partly justifies the premium.

The market is not underpricing ROK's turnaround; it is beginning to price it. On FY26E EPS of $13.21, $433 is 32.8x forward earnings. At the 5-year average multiple of 30.7x, fair value would be ~$406; at 34x it would be ~$449; and at the consensus target of ~$495 it would be 37x. So the stock has already absorbed a lot of good news. The bull case now depends on estimates continuing to move up, while the bear case is that a cyclical peak in orders triggers multiple compression.

As of 2026-08-27, RSI-14 is 41.7, which is neutral rather than oversold. Price is 2.4% below its 20-day SMA (~$444), 5.6% below its 50-day SMA (~$459), and 3.3% above its 200-day SMA (~$419). This is a pullback within a longer-term uptrend, not a breakdown. For timing, the cleaner entries are either a reclaim of the 50-day near $459 or a test of 200-day support near $419; losing $419 would damage the structural uptrend.

• AI data-center and semiconductor capex is a direct demand driver for Rockwell's Logix controls, OTTO AMRs, and industrial software.
• US reshoring and manufacturing-related infrastructure spending continue to support North American automation demand.
• Process industries, food & beverage, and some lifecycle services are still recovering slowly; Q3 book-to-bill was 0.97 in that segment.
• Component/memory inflation and potential tariff adjustments are cost headwinds, partly offset by ~250 bps of planned price realization.
• Higher interest rates and ROK's 1.54 beta make it sensitive to swings in the industrial capex cycle and equity multiple.

• Q4/FY26 earnings expected around November 5, 2026, especially FY27 organic growth guidance and any sign of process-market recovery.
• Continued strength in AI data-center, semiconductor, and warehouse automation orders, plus high-margin software/cybersecurity adoption under NIS2.
• Execution on the $850M FY26 buyback and margin expansion toward the 22.3% adjusted operating margin or higher.

• Valuation risk: at ~32.8x forward earnings and rich vs. its own history, a guidance miss or cyclical downturn could trigger meaningful multiple compression.
• Cyclical demand risk: if industrial orders/investment slow, ROK's revenue and EPS can deteriorate quickly, as seen in FY24.
• Cost and tariff risk: if memory/electronic component inflation or tariff adjustments outpace the ~250 bps price- realization plan, margins will be squeezed.
• Competition and transition risk from the software-led transformation; process end-markets could lag longer than expected.

Rockwell is executing well in a genuine cyclical recovery: raised FY26 guidance to $13.00-$13.30, 10% organic sales growth, 280 bps adjusted margin expansion, and $654M of FCF in the Jun-26 quarter. But at $433 the stock already trades at roughly 33x forward earnings, so the near-term recovery is largely in the price. I am cautiously bullish — a high-quality automation franchise worth owning, but selectively, on pullbacks rather than as a fresh chase at this level.

I used a justified forward P/E of ~34.0x — the midpoint of ROK's 5-year average P/E of 30.7x and a PEG-1.5 multiple on ~25% expected FY26 EPS growth (~37.3x) — applied to FY26E EPS of $13.21. That yields $449.36, reflecting the quality and cyclical recovery premium while staying disciplined about the already-rich valuation.